Basic info
Industry
biotechnology
Sectors
Alternative Medicine
Biotechnology
Immuno-oncology
inflammatory diseases
pharmaceuticals
fibrotic diseases
arginase
Medicinal chemistry
Cancer
chitinase
Small molecule immunomodulators
Immunotherapy
Small Molecule Drug Discovery
Medical
Respiratory diseases
Emergency Medicine
Date founded
2012
Funding rounds raised
Total raised
$7.3M
from 2 investors over 2 rounds
O
OncoArendi Therapeutics raised $3.2M on January 19, 2015
Investors: New Europe Ventures
O
OncoArendi Therapeutics raised $7.3M on December 23, 2014
Investors: NCBR+ Sp. z o.o.